Skip to main content
. 2020 Dec 19;9(12):929. doi: 10.3390/antibiotics9120929

Table 7.

Sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratio, and correlation with a positive outcome (PO for diagnosis of cystitis) using different criteria (mean and 95% CI). CI, confidence interval; PPV, positive predictive value, NPV, negative predictive value; +LR, positive likelihood ratio; −LR, negative likelihood ratio; AUC, area under the curve; PO, positive outcome (diagnosis is correct). Main symptoms and 3 EMA symptoms: urinary frequency, urinary urgency, dysuria; 4 FDA symptoms: urinary frequency, urinary urgency, dysuria, suprapubic pain.

Criteria N (%)
Positive
N (%)
Negative
Sensitivity Specificity PPV NPV +LR −LR AUC Correlation
with PO
ACSS:
typical domain,
sumscore ≥6
96
(96%)
2
(2%)
0.96
(0.90–0.99)
0.98
(0.93–1.00)
0.98
(0.92–1.00)
0.96
(0.90–0.99)
48.00
(12.17–189.38)
0.04
(0.02–0.11)
0.97
(0.95–0.99)
0.94
(0.92–0.95)
ACSS:
main symptoms,
sumscore ≥6
77
(77%)
1
(1%)
0.77
(0.68–0.85)
0.99
(0.95–1.00)
0.99
(0.93–1.00)
0.81
(0.73–0.88)
77.00
(10.92–542.88)
0.23
(0.16–0.33)
0.88
(0.84–0.92)
0.78
(0.72–0.83)
FDA:
at least 2 positive symptom of 4
100
(100%)
33
(33%)
1.00
(0.96–1.00)
0.67
(0.57–0.76)
0.75
(0.67–0.82)
1.00
(0.95–1.00)
3.03
(2.29–4.01)
0.00
(0.00-NA)
0.84
(0.79–0.88)
0.71
(0.63–0.77)
EMA:
at least 1 positive symptom of 3
100
(100%)
22
(22%)
1.00
(0.96–1.00)
0.78
(0.69–0.86)
0.82
(0.74–0.88)
1.00
(0.95–1.00)
4.55
(3.14–6.57)
0.00
(0.00-NA)
0.89
(0.85–0.93)
0.80
(0.74–0.85)